Equities

Celadon Pharmaceuticals PLC

CEL:LSE

Celadon Pharmaceuticals PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)94.70
  • Today's Change-2.80 / -2.87%
  • Shares traded3.19k
  • 1 Year change-37.90%
  • Beta-0.0832
Data delayed at least 20 minutes, as of May 20 2024 10:35 BST.
More ▼

Profile data is unavailable for this security.

About the company

Celadon Pharmaceuticals Plc is a United Kingdom-based pharmaceutical company. The Company is engaged in research, cultivation, manufacturing, and supply of cannabinoid-based medicines. The Company is focused on growing indoor hydroponic cannabis initially for the chronic pain market. It is also focused on improving the quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions, such as autism. The Company's facility comprises an indoor hydroponic cultivation, proprietary GMP extraction and manufacturing and an analytical and R&D laboratory. It also has a minority interest in early-stage biopharma Kingdom therapeutics. The Company's subsidiary, LVL Health is a medical cannabis clinic for chronic pain that owns a medicines and healthcare products regulatory agency (MHRA) conditionally approved cannabis trial using cannabis-based medicinal products to treat chronic pain in the United Kingdom.

  • Revenue in GBP (TTM)20.74k
  • Net income in GBP-8.06m
  • Incorporated2018
  • Employees--
  • Location
    Celadon Pharmaceuticals PLC32-33 Cowcross StreetLondon EC1M 6DFUnited KingdomGBR
  • Phone+44 20 3150 0252
  • Websitehttps://celadonpharma.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Sareum Holdings Plc0.00-4.26m36.70m5.0036.70m5.00
Arecor Therapeutics PLC3.38m-9.42m40.12m51.0040.12m51.00
Venture Life Group PLC51.41m921.00k51.23m165.0051.23m165.00
Celadon Pharmaceuticals PLC20.74k-8.06m63.86m--63.86m--
Poolbeg Pharma PLC0.00-3.93m64.00m8.0064.00m8.00
Eco Animal Health Group Plc88.46m-1.62m79.94m228.0079.94m228.00
Scancell Holdings Plc0.00-11.32m93.73m51.0093.73m51.00
Data as of May 20 2024. Currency figures normalised to Celadon Pharmaceuticals PLC's reporting currency: UK Pound GBX
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.